Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Abstract Scalp cooling therapy (SCT) improves chemotherapy-induced alopecia (CIA), but there are few published data about its efficacy in an Asian-predominant population. We report our tertiary institution experience of SCT in patients with breast or gynaecological cancers undergoing chemotherapy. The Paxman scalp cooling system was employed for eligible women with breast or gynaecological cancers receiving anthracycline or taxane-based chemotherapy.
History, presentation and treatment A 55-year-old female first presented with confused speech of several days in January 2021. She had no other symptoms. A CT scan of the brain performed at an accident & emergency department showed a large tumour in the left frontal lobe. An MRI scan with contrast confirmed left frontal lobe tumour of 3.3 cm x 3.4 cm x 4.2 cm. (Figure 1A) The patient underwent surgery on 5 January 2021.
Objectives To characterise short-term and long-term opioid prescription patterns after cardiac surgery. Design, Setting and Participants We obtained data from a single Australian tertiary hospital from November 2012 to July 2019 and included 2,205 patients who underwent a primary cardiac surgical procedure. Main Outcome and Measures The primary outcome was the dose of opioids at hospital discharge.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
